TY - JOUR
T1 - Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens
T2 - A case report
AU - Rodríguez-Hidalgo, Richar
AU - Carpio, Arturo
AU - Van Den Enden, Erwin
AU - Benítez-Ortiz, Washington
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/4/3
Y1 - 2019/4/3
N2 - Background: Parenchymal neurocysticercosis is a frequent cause of seizures in areas endemic for Taenia solium. At present there is scarce data on the evolution of the levels of circulating metacestodal antigen before, during and after treatment with anthelmintic drugs. Case presentation: A patient with paucisymptomatic neurocysticercosis (NCC) diagnosed by Ag-ELISA, and confirmed by MRI images, was treated with praziquantel, albendazole and dexamethasone. The level of circulating T. solium antigen was determined weekly. Circulating antigen disappeared from his blood within 14 days after the start of the treatment and correlated with the involution of the cysticerci in the brain shown by imaging. Seventeen years later, the patient has not shown any side effect nor symptoms related to the treatment or to NCC. Conclusions: If this encouraging finding is confirmed in a larger series of patients, this technique could be used to determine parasitological cure after treatment and might complement or sometimes replace sequential MRI-imaging of the brain.
AB - Background: Parenchymal neurocysticercosis is a frequent cause of seizures in areas endemic for Taenia solium. At present there is scarce data on the evolution of the levels of circulating metacestodal antigen before, during and after treatment with anthelmintic drugs. Case presentation: A patient with paucisymptomatic neurocysticercosis (NCC) diagnosed by Ag-ELISA, and confirmed by MRI images, was treated with praziquantel, albendazole and dexamethasone. The level of circulating T. solium antigen was determined weekly. Circulating antigen disappeared from his blood within 14 days after the start of the treatment and correlated with the involution of the cysticerci in the brain shown by imaging. Seventeen years later, the patient has not shown any side effect nor symptoms related to the treatment or to NCC. Conclusions: If this encouraging finding is confirmed in a larger series of patients, this technique could be used to determine parasitological cure after treatment and might complement or sometimes replace sequential MRI-imaging of the brain.
KW - Albendazole
KW - Neurocysticercosis
KW - Praziquantel
KW - Taenia solium
KW - Treatment
UR - https://www.scopus.com/pages/publications/85064080785
U2 - 10.1186/s12883-019-1282-x
DO - 10.1186/s12883-019-1282-x
M3 - Artículo
C2 - 30943908
AN - SCOPUS:85064080785
SN - 1471-2377
VL - 19
JO - BMC Neurology
JF - BMC Neurology
IS - 1
M1 - 52
ER -